Personalized Cancer Medicine: Next Steps in the Genomic Era

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2015 Feb 28

PMID 25720594

Citations 3

Authors

S Derks

B Diosdado

Affiliations

Soon will be listed here.

Citing Articles

Cytotoxic Screening of Different Parts from on Selected Cancer Cells.

Sharafi-Badr P, Karoobi S, Monsef-Esfahani H, Ghahremani M, Adhami H Iran J Med Sci. 2022; 47(1):63-72.

PMID: 35017779 PMC: 8743371. DOI: 10.30476/IJMS.2021.89521.2037.

NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy.

Ramesh V, Selvarasu K, Pandian J, Myilsamy S, Shanmugasundaram C, Ganesan K Cell Oncol (Dordr). 2016; 39(6):523-536.

PMID: 27562587 DOI: 10.1007/s13402-016-0294-4.

Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Silva-Oliveira R, Silva V, Martinho O, Cruvinel-Carloni A, Melendez M, Rosa M Cell Oncol (Dordr). 2016; 39(3):253-63.

PMID: 26920031 DOI: 10.1007/s13402-016-0270-z.

References

Mammatas L, Verheul H, Hendrikse N, Yaqub M, Lammertsma A, Menke-van der Houven van Oordt C . Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care. Cell Oncol (Dordr). 2014; 38(1):49-64. DOI: 10.1007/s13402-014-0194-4. View

Prudkin L, Nuciforo P . Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic. Cell Oncol (Dordr). 2014; 38(1):39-48. DOI: 10.1007/s13402-014-0192-6. View

Artez A, Bernabe R, Eerola I, Hemsley F, Jennings J, Kerr D . International network of cancer genome projects. Nature. 2010; 464(7291):993-8. PMC: 2902243. DOI: 10.1038/nature08987. View

Van Neste L, Van Criekinge W . We are all individuals... bioinformatics in the personalized medicine era. Cell Oncol (Dordr). 2014; 38(1):29-37. DOI: 10.1007/s13402-014-0195-3. View

Pesenti C, Gusella M, Sirchia S, Miozzo M . Germline oncopharmacogenetics, a promising field in cancer therapy. Cell Oncol (Dordr). 2015; 38(1):65-89. DOI: 10.1007/s13402-014-0214-4. View